Stauffer CS

Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System, Portland, OR, USA.

15 papers · ORCID

ArticlePsilocybin

Oregon's state-regulated psilocybin services: Early real-world safety signals.

Luoma JB, Chwyl C, Des Jarlais D +6

Europe PMC2026
ArticleMDMA

Prevalence of Potential Contraindications and Risk Factors Relevant to MDMA-Assisted Therapy Among U.S. Veterans with Posttraumatic Stress Disorder.

Hwang CS, Cameron DC, O'Neill AC +4

Europe PMC2026
ArticlePsilocybin

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.

Korthuis PT, Cook RR, Gregoire D +8

Europe PMC2026
ArticleMDMA

Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study.

Kachmarik JE, Loftis JM, Stauffer CS

Europe PMC2026
ArticlePsychedelics

Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey.

Bahceci D, Siefried K, Steele M +9

Europe PMC2025
ArticlePsilocybin

Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs.

Luoma JB, Hoffman K, Wilson-Poe AR +12

Europe PMC2026
ArticleMDMA

Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting.

Perivoliotis D, Knopp K, Remick S +8

Europe PMC2025
ArticlePsilocybin

Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.

Wolfgang AS, McClair VL, Schnurr PP +13

Europe PMC2025
ArticlePsilocybin

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.

Korthuis PT, Hoffman K, Wilson-Poe AR +10

Europe PMC2024
ArticlePsilocybin

Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.

O'Donnell KC, Anderson BT, Barrett FS +9

Europe PMC2024
ArticlePsilocybin

Peer support and psychedelics.

Skiles Z, Dixon JR, Friedrich D +2

Europe PMC2023
ArticlePsilocybin

Group psychedelic therapy: empirical estimates of cost-savings and improved access.

Marseille E, Stauffer CS, Agrawal M +5

Europe PMC2023
ArticlePsilocybin

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.

Brett J, Knock E, Korthuis PT +5

Europe PMC2023
ArticleMDMA

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials.

Stauffer CS, Brown MR, Adams D +2

Europe PMC2022
ArticlePsilocybin

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.

Sarparast A, Thomas K, Malcolm B +1

Europe PMC2022